teniposide
Selected indexed studies
- Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC. (J Immunother Cancer, 2022) [PMID:36002188]
- Teniposide in lymphomas and leukemias. (Semin Oncol, 1992) [PMID:1411640]
- Teniposide (VM-26) in brain tumors. (Semin Oncol, 1992) [PMID:1411642]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC. (2022) pubmed
- Teniposide in lymphomas and leukemias. (1992) pubmed
- Teniposide (VM-26) in brain tumors. (1992) pubmed
- Teniposide: overview of its therapeutic potential in adult cancers. (1994) pubmed
- Teniposide alone and in combination chemotherapy in small cell lung cancer. (1992) pubmed
- Teniposide in adult solid tumors: a historical perspective. (1992) pubmed
- Tellurophene-Tagging of Teniposide Facilitates Monitoring by Mass Cytometry. (2022) pubmed
- Etoposide and teniposide in the treatment of acute leukemia. (1990) pubmed
- The clinical pharmacology of etoposide and teniposide. (1987) pubmed
- Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal diseases. (1988) pubmed